Core Laboratories (CLB) Reports Q3 EPS of $0.48

Go back to Core Laboratories (CLB) Reports Q3 EPS of $0.48

Core Laboratories (CLB) PT Lowered to $115 at Loop Capital

October 25, 2017 6:44 AM EDT

Loop Capital lowered its price target on Core Laboratories (NYSE: CLB) to $115.00 (from $125.00) while maintaining a Buy rating.

... More

ABN Amro Upgrades Core Laboratories (CLB) to Buy

October 25, 2017 6:18 AM EDT

ABN Amro upgraded Core Laboratories (NYSE: CLB) from Hold to Buy with a price target of $117.50 (from $120.00).

The analyst believes the company has proven that in the face of Harvey the company is benefiting from the acceleration of US well completions and believes... More